Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Elife ; 82019 10 08.
Article in English | MEDLINE | ID: mdl-31591959

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) transmission in the hospital setting has been a frequent subject of investigation using bacterial genomes, but previous approaches have not yet fully utilised the extra deductive power provided when multiple pathogen samples are acquired from each host. Here, we used a large dataset of MRSA sequences from multiply-sampled patients to reconstruct colonisation of individuals in a high-transmission setting in a hospital in Thailand. We reconstructed transmission trees for MRSA. We also investigated transmission between anatomical sites on the same individual, finding that this either occurs repeatedly or involves a wide transmission bottleneck. We examined the between-subject bottleneck, finding considerable variation in the amount of diversity transmitted. Finally, we compared our approach to the simpler method of identifying transmission pairs using single nucleotide polymorphism (SNP) counts. This suggested that the optimum threshold for identifying a pair is 39 SNPs, if sensitivities and specificities are equally weighted.


Subject(s)
Cross Infection/transmission , DNA, Bacterial/genetics , Genome, Bacterial/genetics , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Infections/transmission , Adult , Child , Computational Biology/methods , Cross Infection/microbiology , Disease Outbreaks , Genetic Variation , Humans , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/physiology , Phylogeny , Polymorphism, Single Nucleotide , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Thailand/epidemiology , Whole Genome Sequencing/methods
2.
Elife ; 82019 02 22.
Article in English | MEDLINE | ID: mdl-30794157

ABSTRACT

Pyomyositis is a severe bacterial infection of skeletal muscle, commonly affecting children in tropical regions, predominantly caused by Staphylococcus aureus. To understand the contribution of bacterial genomic factors to pyomyositis, we conducted a genome-wide association study of S. aureus cultured from 101 children with pyomyositis and 417 children with asymptomatic nasal carriage attending the Angkor Hospital for Children, Cambodia. We found a strong relationship between bacterial genetic variation and pyomyositis, with estimated heritability 63.8% (95% CI 49.2-78.4%). The presence of the Panton-Valentine leucocidin (PVL) locus increased the odds of pyomyositis 130-fold (p=10-17.9). The signal of association mapped both to the PVL-coding sequence and to the sequence immediately upstream. Together these regions explained over 99.9% of heritability (95% CI 93.5-100%). Our results establish staphylococcal pyomyositis, like tetanus and diphtheria, as critically dependent on a single toxin and demonstrate the potential for association studies to identify specific bacterial genes promoting severe human disease.


Subject(s)
Bacterial Toxins/metabolism , Exotoxins/metabolism , Leukocidins/metabolism , Pyomyositis/physiopathology , Staphylococcal Infections/physiopathology , Staphylococcus aureus/metabolism , Virulence Factors/metabolism , Bacterial Toxins/genetics , Cambodia , Exotoxins/genetics , Genome-Wide Association Study , Humans , Leukocidins/genetics , Staphylococcus aureus/genetics , Virulence Factors/genetics
3.
mBio ; 8(4)2017 07 05.
Article in English | MEDLINE | ID: mdl-28679748

ABSTRACT

Staphylococcus argenteus is a newly named species previously described as a divergent lineage of Staphylococcus aureus that has recently been shown to have a global distribution. Despite growing evidence of the clinical importance of this species, knowledge about its population epidemiology and genomic architecture is limited. We used whole-genome sequencing to evaluate and compare S. aureus (n = 251) and S. argenteus (n = 68) isolates from adults with staphylococcal sepsis at several hospitals in northeastern Thailand between 2006 and 2013. The majority (82%) of the S. argenteus isolates were of multilocus sequence type 2250 (ST2250). S. aureus was more diverse, although 43% of the isolates belonged to ST121. Bayesian analysis suggested an S. argenteus ST2250 substitution rate of 4.66 (95% confidence interval [CI], 3.12 to 6.38) mutations per genome per year, which was comparable to the S. aureus ST121 substitution rate of 4.07 (95% CI, 2.61 to 5.55). S. argenteus ST2250 emerged in Thailand an estimated 15 years ago, which contrasts with the S. aureus ST1, ST88, and ST121 clades that emerged around 100 to 150 years ago. Comparison of S. argenteus ST2250 genomes from Thailand and a global collection indicated a single introduction into Thailand, followed by transmission to local and more distant countries in Southeast Asia and further afield. S. argenteus and S. aureus shared around half of their core gene repertoire, indicating a high level of divergence and providing strong support for their classification as separate species. Several gene clusters were present in ST2250 isolates but absent from the other S. argenteus and S. aureus study isolates. These included multiple exotoxins and antibiotic resistance genes that have been linked previously with livestock-associated S. aureus, consistent with a livestock reservoir for S. argenteus These genes appeared to be associated with plasmids and mobile genetic elements and may have contributed to the biological success of ST2250.IMPORTANCE In this study, we used whole-genome sequencing to understand the genome evolution and population structure of a systematic collection of ST2250 S. argenteus isolates. A newly identified ancestral species of S. aureus, S. argenteus has become increasingly known as a clinically important species that has been reported recently across various countries. Our results indicate that S. argenteus has spread at a relatively rapid pace over the past 2 decades across northeastern Thailand and acquired multiple exotoxin and antibiotic resistance genes that have been linked previously with livestock-associated S. aureus Our findings highlight the clinical importance and potential pathogenicity of S. argenteus as a recently emerging pathogen.


Subject(s)
Evolution, Molecular , Livestock/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Staphylococcus/genetics , Adult , Animals , Anti-Bacterial Agents/pharmacology , Bayes Theorem , Disease Reservoirs/microbiology , Drug Resistance, Multiple, Bacterial/genetics , Genetic Variation , Genome, Bacterial , High-Throughput Nucleotide Sequencing/methods , Humans , Microbial Sensitivity Tests , Multilocus Sequence Typing , Mutation , Sepsis/microbiology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/transmission , Staphylococcus/classification , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Thailand , Virulence Factors/genetics
4.
Br Med Bull ; 117(1): 121-38, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26872859

ABSTRACT

INTRODUCTION: The incidence of vertebral osteomyelitis is increasing, attributed to an ageing population with inherent co-morbidities and improved case ascertainment. SOURCES OF DATA: References were retrieved from the PubMed database using the terms 'vertebral osteomyelitis' and 'spondylodiscitis' between January 1, 2009 and April 30, 2014 published in English as checked in May 2014 (>1000 abstracts checked). AREAS OF AGREEMENT: Blood cultures and whole spine imaging with magnetic resonance imaging are essential investigations. Thorough debridement is the mainstay of surgical management, although placing metalwork in active infection is becoming increasingly common. AREAS OF CONTROVERSY: The extent of pursuing spinal biopsies to determine aetiology, antimicrobial choices and duration, monitoring the response to treatment, and surgical techniques and timing all vary widely in clinical practice with heterogeneous studies limiting comparisons. Surgery, rather than conservative approaches, is being proposed as the default management choice, because it can, in carefully selected patients, offer faster reduction in pain scores and improved quality of life. AREAS TIMELY FOR DEVELOPING RESEARCH: Further studies are needed to define the most effective technique for spinal biopsies to maximize determining aetiology. High-quality trials are required to provide an evidence base for both the medical and surgical management of vertebral osteomyelitis, including challenging medical management as the default option.


Subject(s)
Osteomyelitis/diagnosis , Osteomyelitis/therapy , Spinal Diseases/diagnosis , Spinal Diseases/therapy , Anti-Bacterial Agents/therapeutic use , Debridement/methods , Discitis/diagnosis , Discitis/epidemiology , Discitis/microbiology , Discitis/therapy , Humans , Osteomyelitis/epidemiology , Osteomyelitis/microbiology , Spinal Diseases/epidemiology , Spinal Diseases/microbiology
5.
J Clin Microbiol ; 53(3): 1005-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25568440

ABSTRACT

Molecular typing of 246 Staphylococcus aureus isolates from unselected patients in Thailand showed that 10 (4.1%) were actually Staphylococcus argenteus. Contrary to the suggestion that S. argenteus is less virulent than S. aureus, we demonstrated comparable rates of morbidity, death, and health care-associated infection in patients infected with either of these two species.


Subject(s)
Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus/classification , Staphylococcus/isolation & purification , Adolescent , Adult , Aged , Cohort Studies , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/mortality , Cross Infection/pathology , Female , Humans , Male , Middle Aged , Molecular Epidemiology , Molecular Typing , Staphylococcal Infections/mortality , Staphylococcal Infections/pathology , Staphylococcus/genetics , Survival Analysis , Thailand/epidemiology , Young Adult
6.
Genome Res ; 25(1): 111-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25491771

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infection. Whole-genome sequencing of MRSA has been used to define phylogeny and transmission in well-resourced healthcare settings, yet the greatest burden of nosocomial infection occurs in resource-restricted settings where barriers to transmission are lower. Here, we study the flux and genetic diversity of MRSA on ward and individual patient levels in a hospital where transmission was common. We repeatedly screened all patients on two intensive care units for MRSA carriage over a 3-mo period. All MRSA belonged to multilocus sequence type 239 (ST 239). We defined the population structure and charted the spread of MRSA by sequencing 79 isolates from 46 patients and five members of staff, including the first MRSA-positive screen isolates and up to two repeat isolates where available. Phylogenetic analysis identified a flux of distinct ST 239 clades over time in each intensive care unit. In total, five main clades were identified, which varied in the carriage of plasmids encoding antiseptic and antimicrobial resistance determinants. Sequence data confirmed intra- and interwards transmission events and identified individual patients who were colonized by more than one clade. One patient on each unit was the source of numerous transmission events, and deep sampling of one of these cases demonstrated colonization with a "cloud" of related MRSA variants. The application of whole-genome sequencing and analysis provides novel insights into the transmission of MRSA in under-resourced healthcare settings and has relevance to wider global health.


Subject(s)
Cross Infection/microbiology , Disease Outbreaks , Methicillin-Resistant Staphylococcus aureus/genetics , Phylogeny , Adult , Bacterial Typing Techniques , Child , Computational Biology , DNA, Bacterial/genetics , High-Throughput Nucleotide Sequencing , Humans , Linear Models , Methicillin-Resistant Staphylococcus aureus/classification , Polymorphism, Single Nucleotide , Prospective Studies , Sequence Analysis, DNA , Staphylococcal Infections/microbiology
7.
PLoS One ; 7(2): e29858, 2012.
Article in English | MEDLINE | ID: mdl-22363410

ABSTRACT

BACKGROUND: The Surviving Sepsis Campaign (SSC) guidelines describe best practice for the management of severe sepsis and septic shock in developed countries, but most deaths from sepsis occur where healthcare is not sufficiently resourced to implement them. Our objective was to define the feasibility and basis for modified guidelines in a resource-restricted setting. METHODS AND FINDINGS: We undertook a detailed assessment of sepsis management in a prospective cohort of patients with severe sepsis caused by a single pathogen in a 1,100-bed hospital in lower-middle income Thailand. We compared their management with the SSC guidelines to identify care bundles based on existing capabilities or additional activities that could be undertaken at zero or low cost. We identified 72 patients with severe sepsis or septic shock associated with S. aureus bacteraemia, 38 (53%) of who died within 28 days. One third of patients were treated in intensive care units (ICUs). Numerous interventions described by the SSC guidelines fell within existing capabilities, but their implementation was highly variable. Care available to patients on general wards covered the fundamental principles of sepsis management, including non-invasive patient monitoring, antimicrobial administration and intravenous fluid resuscitation. We described two additive care bundles, one for general wards and the second for ICUs, that if consistently performed would be predicted to improve outcome from severe sepsis. CONCLUSION: It is feasible to implement modified sepsis guidelines that are scaled to resource availability, and that could save lives prior to the publication of international guidelines for developing countries.


Subject(s)
Developing Countries/statistics & numerical data , Guidelines as Topic , Health Promotion/statistics & numerical data , Health Resources/statistics & numerical data , Sepsis/epidemiology , Sepsis/microbiology , Staphylococcus aureus/physiology , Adult , Child , Cohort Studies , Feasibility Studies , Female , Hemodynamics , Humans , Male , Resuscitation , Sepsis/physiopathology , Sepsis/therapy , Thailand/epidemiology
8.
Am J Trop Med Hyg ; 84(2): 313-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21292906

ABSTRACT

We previously described the first reported isolation of methicillin-resistant Staphylococcus aureus (MRSA) (a case series of pediatric community-associated MRSA infections) in Cambodia. We define the rate of pediatric MRSA carriage in the same population and characterize the associated bacterial genotypes by using pulsed-field gel electrophoresis and multilocus sequence typing. A prospective cohort study of MRSA carriage conducted over one month at the Angkor Hospital for Children, Siem Reap, Cambodia, identified MRSA carriage in 87 (3.5%) of 2,485 children who came to the outpatient department, and 6 (4.1%) of 145 inpatients, including at least two with cases of nosocomial acquisition. Genotyping of all 93 MRSA isolates resolved 5 genotypes. Most (91%) isolates were assigned to sequence type 834. Only 28 (32%) of 87 MRSA carriers identified in the outpatient department had no history of recent healthcare contact. The study findings have important implications for healthcare in a setting where diagnostic microbiology and access to antimicrobial drugs with efficacy against MRSA are limited.


Subject(s)
Carrier State/epidemiology , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Skin Infections/epidemiology , Anti-Bacterial Agents/therapeutic use , Cambodia/epidemiology , Carrier State/drug therapy , Carrier State/microbiology , Child , Child, Preschool , Communicable Diseases, Emerging/drug therapy , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/microbiology , Community-Acquired Infections/drug therapy , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Disk Diffusion Antimicrobial Tests , Drug Resistance, Multiple, Bacterial , Electrophoresis, Gel, Pulsed-Field , Genotype , Humans , Infant , Methicillin/therapeutic use , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Skin Infections/drug therapy , Staphylococcal Skin Infections/microbiology
9.
Science ; 327(5964): 469-74, 2010 Jan 22.
Article in English | MEDLINE | ID: mdl-20093474

ABSTRACT

Current methods for differentiating isolates of predominant lineages of pathogenic bacteria often do not provide sufficient resolution to define precise relationships. Here, we describe a high-throughput genomics approach that provides a high-resolution view of the epidemiology and microevolution of a dominant strain of methicillin-resistant Staphylococcus aureus (MRSA). This approach reveals the global geographic structure within the lineage, its intercontinental transmission through four decades, and the potential to trace person-to-person transmission within a hospital environment. The ability to interrogate and resolve bacterial populations is applicable to a range of infectious diseases, as well as microbial ecology.


Subject(s)
Cross Infection/microbiology , Genome, Bacterial , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Infections/microbiology , Asia/epidemiology , Bacterial Typing Techniques , Cross Infection/epidemiology , Cross Infection/transmission , Europe/epidemiology , Evolution, Molecular , Genomics/methods , Humans , Likelihood Functions , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , Polymorphism, Single Nucleotide , Sequence Analysis, DNA , South America/epidemiology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/transmission , Time Factors , United States/epidemiology
10.
PLoS One ; 4(8): e6512, 2009 Aug 04.
Article in English | MEDLINE | ID: mdl-19652705

ABSTRACT

BACKGROUND: Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world. The factors determining mortality in developing countries have not been identified. METHODS: A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period. All-cause and S. aureus-attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL). PRINCIPAL FINDINGS: A total of 270 patients with invasive S. aureus infection were recruited. The range of clinical manifestations was broad and comparable to that described in developed countries. All-cause and S. aureus-attributable mortality rates were 26% and 20%, respectively. Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p<0.001) on univariate analysis. Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p<0.001). Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus-attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival. CONCLUSIONS: Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world. Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.


Subject(s)
Staphylococcal Infections/mortality , Staphylococcus aureus/isolation & purification , Adolescent , Adult , Anti-Bacterial Agents/therapeutic use , Bacterial Toxins/genetics , Developing Countries , Exotoxins/genetics , Female , Humans , Leukocidins/genetics , Male , Middle Aged , Prospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/genetics , Staphylococcal Infections/pathology , Staphylococcus aureus/pathogenicity , Young Adult
11.
Lancet Infect Dis ; 9(2): 130-5, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19179228

ABSTRACT

By contrast with high-income countries, Staphylococcus aureus disease ranks low on the public-health agenda in low-income countries. We undertook a literature review of S aureus disease in resource-limited countries in south and east Asia, and found that its neglected status as a developing world pathogen does not equate with low rates of disease. The incidence of the disease seems to be highest in neonates, its range of clinical manifestations is as broad as that seen in other settings, and the mortality rate associated with serious S aureus infection, such as bacteraemia, is as high as 50%. The prevalence of meticillin-resistant S aureus (MRSA) infection across much of resource-limited Asia is largely unknown. Antibiotic drugs are readily and widely available from pharmacists in most parts of Asia, where ease of purchase and frequent self-medication are likely to be major drivers in the emergence of drug resistance. In our global culture, the epidemiology of important drug-resistant pathogens in resource-limited countries is inextricably linked with the health of both developing and developed communities. An initiative is needed to raise the profile of S aureus disease in developing countries, and to define a programme of research to find practical solutions to the health-care challenges posed by this important global pathogen.


Subject(s)
Developing Countries , Drug Resistance, Bacterial , Staphylococcal Infections/epidemiology , Anti-Bacterial Agents/pharmacology , Asia/epidemiology , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/prevention & control , Cross Infection/transmission , Humans , Methicillin-Resistant Staphylococcus aureus , Risk Factors , Staphylococcal Infections/microbiology , Staphylococcal Infections/prevention & control , Staphylococcal Infections/transmission , Staphylococcus aureus/drug effects
12.
PLoS One ; 4(1): e4308, 2009.
Article in English | MEDLINE | ID: mdl-19180198

ABSTRACT

BACKGROUND: Most information on invasive Staphylococcus aureus infections comes from temperate countries. There are considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. METHODS: A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. PRINCIPAL FINDINGS: Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. CONCLUSIONS: S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.


Subject(s)
Bacteremia/epidemiology , Drug Resistance, Microbial , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cross Infection/epidemiology , Cross Infection/microbiology , Endocarditis/epidemiology , Endocarditis/microbiology , Humans , Infant , Infant, Newborn , Middle Aged , Prevalence , Prospective Studies , Staphylococcal Infections/microbiology , Staphylococcal Infections/mortality , Staphylococcus aureus/drug effects , Thailand/epidemiology , Tropical Climate , Young Adult
13.
J Clin Microbiol ; 46(4): 1520-2, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18234867

ABSTRACT

We describe and validate a novel PCR assay to detect the pandemic hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) lineage ST 239. Results based on previously uncharacterized isolates from a hospital in northeast Thailand support the view that at least 90% of HA-MRSA isolates in mainland Asia correspond to ST 239 or close relatives.


Subject(s)
Methicillin Resistance , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Asia/epidemiology , Cross Infection/epidemiology , Cross Infection/microbiology , Disease Outbreaks , Hospitals , Humans , Polymerase Chain Reaction/methods , Sensitivity and Specificity , Staphylococcal Infections/epidemiology , Staphylococcus aureus/classification , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...